Limited effectiveness with a 10-day bismuth-containing quadruple therapy (Pylera® ) in third-line recue treatment for Helicobacter pylori infection. A real-life multicenter study
出版年份 2017 全文链接
标题
Limited effectiveness with a 10-day bismuth-containing quadruple therapy (Pylera®
) in third-line recue treatment for Helicobacter pylori
infection. A real-life multicenter study
作者
关键词
-
出版物
HELICOBACTER
Volume 22, Issue 5, Pages e12423
出版商
Wiley
发表日期
2017-08-04
DOI
10.1111/hel.12423
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- New bismuth-containing quadruple therapy in patients infected with Helicobacter pylori : A first Italian experience in clinical practice
- (2017) Antonio Tursi et al. HELICOBACTER
- IV Conferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori
- (2016) Javier P. Gisbert et al. Gastroenterologia y Hepatologia
- The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults
- (2016) Carlo A. Fallone et al. GASTROENTEROLOGY
- Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report
- (2016) P Malfertheiner et al. GUT
- Epidemiology ofHelicobacter pyloriinfection
- (2016) Mārcis Leja et al. HELICOBACTER
- Rescue therapy with bismuth-containing quadruple therapy in patients infected with metronidazole-resistant Helicobacter pylori strains
- (2016) Nelly Muller et al. Clinics and Research in Hepatology and Gastroenterology
- Systematic review: third-line susceptibility-guided treatment for Helicobacter pylori infection
- (2016) Ignasi Puig et al. Therapeutic Advances in Gastroenterology
- Review article: the global emergence ofHelicobacter pyloriantibiotic resistance
- (2015) I. Thung et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- How to Effectively Use Bismuth Quadruple Therapy
- (2015) David Y. Graham et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication ofHelicobacter pylori
- (2014) J. C. Delchier et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Prevalence of Helicobacter pylori Infection Worldwide: A Systematic Review of Studies with National Coverage
- (2014) Bárbara Peleteiro et al. DIGESTIVE DISEASES AND SCIENCES
- Second and third line treatment options forHelicobacter pylorieradication
- (2014) Mingjun Song WORLD JOURNAL OF GASTROENTEROLOGY
- Third-Line Rescue Therapy with Bismuth-Containing Quadruple Regimen After Failure of Two Treatments (with Clarithromycin and Levofloxacin) for H. pylori Infection
- (2013) J. P. Gisbert et al. DIGESTIVE DISEASES AND SCIENCES
- III Conferencia Española de Consenso sobre la infección por Helicobacter pylori
- (2013) Javier P. Gisbert et al. Gastroenterologia y Hepatologia
- How antibiotic resistances could changeHelicobacter pyloritreatment: A matter of geography?
- (2013) Enzo Ierardi WORLD JOURNAL OF GASTROENTEROLOGY
- Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection
- (2012) A. G. McNicholl et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report
- (2012) Peter Malfertheiner et al. GUT
- Helicobacter pyloriresistance to antibiotics in Europe and its relationship to antibiotic consumption
- (2012) Francis Megraud et al. GUT
- Comparison of the Eradication Rate between 1- and 2-Week Bismuth-Containing Quadruple Rescue Therapies for Helicobacter pylori Eradication
- (2012) Jai Hoon Yoon et al. Gut and Liver
- Greater Than 95% Success with 14-day Bismuth Quadruple Anti-Helicobacter pyloriTherapy: A Pilot Study in US Hispanics
- (2012) Cesar O. Salazar et al. HELICOBACTER
- Review article: rifabutin in the treatment of refractory Helicobacter pylori infection
- (2011) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Second-line Helicobacter pylori Eradication: A Randomized Comparison of 1-week or 2-week Bismuth-containing Quadruple Therapy
- (2011) Jun-Won Chung et al. HELICOBACTER
- Effectiveness and Safety of Repeated Quadruple Therapy in Helicobacter pylori Infection After Failure of Second-line Quadruple Therapy
- (2011) Sang Kyu Lee et al. HELICOBACTER
- Twice-a-Day Bismuth-Containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Trial of 10 and 14 Days
- (2011) Maria Pina Dore et al. HELICOBACTER
- Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial
- (2011) Peter Malfertheiner et al. LANCET
- Helicobacter pylori Infection
- (2011) Deng-Chyang Wu et al. MEDICINE
- Bismuth-Containing Quadruple Therapy as Second-Line Treatment forHelicobacter pyloriInfection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate in Korea
- (2010) Byoung Hwan Lee et al. HELICOBACTER
- Pylera®for the eradication ofHelicobacter pyloriinfection
- (2009) Aamir Saleem et al. Expert Review of Anti-Infective Therapy
- Comparison of short- and long-term treatment protocols and the results of second-line quadruple therapy in children with Helicobacter pylori infection
- (2008) Yusuf Usta et al. JOURNAL OF GASTROENTEROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started